CalciMedica Announces Appointment of Dr. Alan Glicklich to Board of Directors
LA JOLLA, Calif. , Jan. 14, 2025 /PRNewswire/ -- CalciMedica Inc. (" CalciMedica " or the "Company") (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute and chronic inflammatory and
